Consolidated Statements of Loss and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Revenues from product sales	$ 0	$ 196
Operating Expenses
Cost of sales of products	0	(76)
Research and development expenses, net of government assistance	(5,559)	(4,173)
General and administrative expenses	(9,263)	(5,521)
Sales and marketing	(518)	(1,142)
Impairment of Intangible assets	0	(3,706)
Impairment of Equipment	0	(1,584)
Impairment of Other assets and prepaid	(249)	(413)
Loss from operating activities	(15,589)	(16,419)
Financial income (expenses)	5,122	(3,259)
Loss before income tax recovery	(10,467)	(19,678)
Income tax recovery	648	0
Net loss and total comprehensive loss	$ (9,819)	$ (19,678)
Basic and diluted loss per share (in dollars per share)	$ (0.27)	$ (1.33)
Weighted average number of shares outstanding (in shares)	36,841,762	14,828,232